Get the Stockscreener App
0.3497
0.11%
0.0004
After Hours:
.36
0.0103
+2.95%
Senseonics Holdings Inc stock is traded at $0.3497, with a volume of 2.93M.
It is up +0.11% in the last 24 hours and down -10.13% over the past month.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
See More
Previous Close:
$0.3493
Open:
$0.3493
24h Volume:
2.93M
Relative Volume:
0.91
Market Cap:
$190.66M
Revenue:
$22.39M
Net Income/Loss:
$-60.39M
P/E Ratio:
-1.9235
EPS:
-0.1818
Net Cash Flow:
$-70.51M
1W Performance:
+0.52%
1M Performance:
-10.13%
6M Performance:
-34.16%
1Y Performance:
-42.09%
1-Day Range:
$0.3418
$0.3585
1-Week Range:
$0.335
$0.3621
52-Week Range:
$0.32
$0.75
Senseonics Holdings Inc Stock (SENS) Company Profile
Name
Senseonics Holdings Inc
Sector
Industry
Phone
301-515-7260
Address
20451 Seneca Meadows Parkway, Germantown, MD
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-05-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-21-21 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-20-21 | Downgrade | Craig Hallum | Hold → Sell |
| Aug-11-20 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-11-20 | Upgrade | Craig Hallum | Sell → Hold |
| Mar-13-20 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-13-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-13-19 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-23-19 | Initiated | Stifel | Buy |
| Jul-05-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-29-19 | Initiated | Piper Jaffray | Neutral |
| Aug-24-18 | Initiated | Dougherty & Company | Buy |
View All
Senseonics Holdings Inc Stock (SENS) Latest News
Senseonics (NYSE:SENS) Earns Sell Rating from Analysts at StockNews.com - MarketBeat
Senseonics Stock Down Despite New FDA Approval for Eversense 365 - MSN
Senseonics Stock Down Despite New FDA Approval for Eversense 365 - Yahoo Finance
Senseonics (NYSE:SENS) Now Covered by Analysts at StockNews.com - Defense World
State of New Jersey Common Pension Fund D Sells 27,371 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Sensata Technologies (NYSE:ST) Releases Q3 2024 Earnings Guidance - Defense World
SenesTech stock hits 52-week low at $2.4 amid sharp decline - Investing.com
Senseonics Eversense 365 glucose monitor cleared in the U.S. - MSN
Eversense 365, a 1-Year CGM, Cleared by the FDA - diaTribe Foundation
FDA Clears First 1-Year CGM for Diabetes - Drug Topics
Investing in Senseonics Holdings Inc (SENS): What You Must Know - Knox Daily
FDA Clearance Announcement Sends Small Cap Soaring - MSN
Senseonics and Ascensia announce FDA approval for one-year CGM system - Medical Device Network
Market Highlights: Senseonics Holdings Inc (SENS) Ends on a High Note at 0.44 - The Dwinnex
Stifel maintains Buy rating on Senseonics, cites FDA approval By Investing.com - Investing.com Canada
Senseonics and Ascensia announce FDA approval for one-year CGM system - Yahoo Finance
FDA approves Eversense 365 as year-long diabetes monitor - Investing.com
FDA Clears Eversense® 365: The World’s First One-Year CGM System - HIT Consultant
FDA clears Senseonic’s Eversense one-year implantable CGM - BioWorld Online
SENS’s Market Whiplash: -22.86% YTD Decline, 6.54% Rise in 30 Days - The InvestChronicle
Long-Term CGM System Eversense 365 Gets FDA Clearance - Monthly Prescribing Reference
Stifel maintains Buy rating on Senseonics, cites FDA approval By Investing.com - Investing.com Australia
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
CME FX Index (DTFX) QuotePress Release - The Globe and Mail
Senseonics Wins FDA Clearance for Year-Long CGM - MD+DI
TSX Renewable and Clean Tech Index (TXCT) QuotePress Release - The Globe and Mail
TSX Smallcap Select Index (TXSC) QuotePress Release - The Globe and Mail
Senseonics receives FDA clearance for one-year CGM - MedTech Dive
FDA approves Eversense 365 as year-long diabetes monitor - Investing.com India
Senseonics Announces first CGM - Baystreet.ca
Stifel maintains Buy rating on Senseonics, cites FDA approval - Investing.com India
FDA OKs Senseonics' Eversense 365-Day Implantable CGM - MPO-mag
Senseonics stock gains on FDA nod for Eversense 365 (NYSE:SENS) - Seeking Alpha
Senseonics receives FDA clearance for one-year CGM - Yahoo Finance
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM - QLifePro
Senseonics receives FDA clearance for Eversense 365 CGM system - TipRanks
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM - GlobeNewswire
Eversense 365 Receives FDA Clearance: The World’s First One Year CGM - Morningstar
Headlands Technologies LLC Sells 3,234 Shares of Sensata Technologies Holding plc (NYSE:ST) - Defense World
Perhaps timely catching Senseonics Holdings Inc (SENS) would be a good idea - SETE News
Daiwa Securities Group Inc. Has $786,000 Stock Position in Sensata Technologies Holding plc (NYSE:ST) - Defense World
StockNews.com Begins Coverage on Senseonics (NYSE:SENS) - MarketBeat
The growth track for Senseonics Holdings Inc (SENS) has changed recently - SETE News
Senseonics Holdings Inc (SENS)’s highs and lows: A closer look at its stock price fluctuations - US Post News
Closing Figures: Senseonics Holdings Inc (SENS)’s Negative Finish at 0.32, Down -9.41 - The Dwinnex
Senseonics Holdings Inc: Navigating a Turbulent Year, Up -57.00% from 52-Week Low - The InvestChronicle
Senseonics Holdings Inc [SENS] Revenue clocked in at $24.04 million, down -37.55% YTD: What’s Next? - The DBT News
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference - ForexTV.com
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewswire
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference - StockTitan
SENS stock touches 52-week low at $0.36 amid market challenges - Investing.com India
Senseonics Holdings Inc Stock (SENS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.25%
1.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):